SNY News and Press, Sanofi From 04/09/24

2024-04-09 05:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-05 13:00:48 ET More on Immunic Immunic, Inc. (IMUX) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Immunic Historical earnings data for Immunic Financial information for Immunic Read the full article on Seeking Alpha...

2024-04-04 08:20:35 ET More on CureVac BV CureVac: No Momentum In Sight Seeking Alpha’s Quant Rating on CureVac BV Historical earnings data for CureVac BV Financial information for CureVac BV Read the full article on Seeking Alpha For f...

2024-04-03 17:45:51 ET French drugmaker Sanofi ( NASDAQ: SNY ) on Wednesday said it had agreed to settle about 4K lawsuits in all U.S. states outside of Del. over accusations that its Zantac heartburn drug caused cancer. ... Read the full article on Seeking Alpha Fo...

2024-04-03 15:00:03 ET Jasper Hellweg from Argus Research issued a price target of $55.00 for SNY on 2024-04-03 12:55:00. The adjusted price target was set to $55.00. At the time of the announcement, SNY was trading at $48. The overall price target consensus is at $48.07...

2024-03-31 21:35:02 ET More on Regeneron, Sanofi Regeneron's Triple Threat: Eylea, Libtayo, And Dupixent Dominate Sanofi: My Top Pick In Big Pharma Regeneron Pharmaceuticals, Inc. (REGN) Leerink Partners Global Biopharma Conference (Transcript) U.S. CDC warns...

2024-03-30 10:50:43 ET More on GSK, Pfizer, etc. Sanofi: My Top Pick In Big Pharma Pfizer: Attractive Valuation And A Strong Pipeline Mitigate Patent Cliff Concerns Sanofi (SNY) Barclays 26th Annual Global Healthcare Conference (Transcript) Pfizer, Astellas f...

2024-03-27 07:03:30 ET Beyfortus (nirsevimab), a single-dose monoclonal antibody developed and commercialized in partnership by AstraZeneca ( NASDAQ: AZN ) and Sanofi ( NASDAQ: SNY ), has been approved in Japan for the prevention of lower respiratory tract disease (LRTD) cau...

2024-03-25 13:47:00 ET Summary Boeing's top boss Dave Calhoun plans to step down at the end of the year. Mizuho turns cautious on the EV sector, downgrades Tesla, Rivian, and Nio. Look beyond the Magnificent 7 to the GRANOLAS in Europe - Goldman Sachs. Listen below o...

2024-03-25 02:07:51 ET Summary Sanofi has underperformed the U.S. stock market lately but now offers one of the smartest growth-at-a-reasonable-price setups in Big Pharma. Sanofi is best known for its patented drug Dupixent and numerous vaccines manufactured for global use, which ...